CDK4 and cancer: Upon light irradiation, Opto-PROTAC can be cleaved to release free PROTAC, inducing the ubiquitination and proteasomal degradation of CDK4/6 and G1 cell-cycle arrest for enhanced specificity in cancer therapy.